{"symbol": "AKBA", "companyName": "Akebia Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.akebia.com", "description": "Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.", "CEO": "John P. Butler", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}